Correlation Between Relmada Therapeutics and Emergent Biosolutions
Can any of the company-specific risk be diversified away by investing in both Relmada Therapeutics and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Relmada Therapeutics and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Relmada Therapeutics and Emergent Biosolutions, you can compare the effects of market volatilities on Relmada Therapeutics and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Relmada Therapeutics with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of Relmada Therapeutics and Emergent Biosolutions.
Diversification Opportunities for Relmada Therapeutics and Emergent Biosolutions
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between Relmada and Emergent is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Relmada Therapeutics and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and Relmada Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Relmada Therapeutics are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of Relmada Therapeutics i.e., Relmada Therapeutics and Emergent Biosolutions go up and down completely randomly.
Pair Corralation between Relmada Therapeutics and Emergent Biosolutions
Given the investment horizon of 90 days Relmada Therapeutics is expected to under-perform the Emergent Biosolutions. But the stock apears to be less risky and, when comparing its historical volatility, Relmada Therapeutics is 1.29 times less risky than Emergent Biosolutions. The stock trades about -0.03 of its potential returns per unit of risk. The Emergent Biosolutions is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 244.00 in Emergent Biosolutions on September 14, 2024 and sell it today you would earn a total of 604.00 from holding Emergent Biosolutions or generate 247.54% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.6% |
| Values | Daily Returns |
Relmada Therapeutics vs. Emergent Biosolutions
Performance |
| Timeline |
| Relmada Therapeutics |
| Emergent Biosolutions |
Relmada Therapeutics and Emergent Biosolutions Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Relmada Therapeutics and Emergent Biosolutions
The main advantage of trading using opposite Relmada Therapeutics and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Relmada Therapeutics position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.| Relmada Therapeutics vs. Cytokinetics | Relmada Therapeutics vs. Edgewise Therapeutics | Relmada Therapeutics vs. Dyne Therapeutics | Relmada Therapeutics vs. Third Harmonic Bio |
| Emergent Biosolutions vs. Zoetis Inc | Emergent Biosolutions vs. Bausch Health Companies | Emergent Biosolutions vs. Neurocrine Biosciences | Emergent Biosolutions vs. Akanda Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |